These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3669256)

  • 1. Phenylpropanolamine in patients with autonomic impairment.
    Kroenke K; Omori D; Simmons J
    JAMA; 1987 Dec; 258(21):3121-2. PubMed ID: 3669256
    [No Abstract]   [Full Text] [Related]  

  • 2. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment.
    Biaggioni I; Onrot J; Stewart CK; Robertson D
    JAMA; 1987 Jul; 258(2):236-9. PubMed ID: 3599310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water potentiates the pressor effect of ephedra alkaloids.
    Jordan J; Shannon JR; Diedrich A; Black B; Robertson D; Biaggioni I
    Circulation; 2004 Apr; 109(15):1823-5. PubMed ID: 15066944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylpropanolamine and blood pressure.
    Morgan JP; Puder KS; Wang BW
    Clin Pharmacol Ther; 1986 Jan; 39(1):102-3. PubMed ID: 3943264
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylpropanolamine and blood pressure.
    Noble RE
    Lancet; 1982 Jun; 1(8286):1419. PubMed ID: 6123711
    [No Abstract]   [Full Text] [Related]  

  • 6. The pressor effect of phenylpropanolamine.
    Pentel P; O'Connell MB
    JAMA; 1989 Nov; 262(17):2386-7. PubMed ID: 2795823
    [No Abstract]   [Full Text] [Related]  

  • 7. Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine.
    Stockley CS; Wing LM; Tonkin AL; Miners JO
    Clin Pharmacol Ther; 1994 Jan; 55(1):35-43. PubMed ID: 8299314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual variability in the blood pressure response to intravenous phenylpropanolamine: a pharmacokinetic and pharmacodynamic investigation.
    O'Connell MB; Pentel PR; Zimmerman CL
    Clin Pharmacol Ther; 1989 Mar; 45(3):252-9. PubMed ID: 2920500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacodynamic interaction between caffeine and phenylpropanolamine.
    Brown NJ; Ryder D; Branch RA
    Clin Pharmacol Ther; 1991 Oct; 50(4):363-71. PubMed ID: 1914371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phenylpropanolamine on human sympathetic nervous system function.
    Lake CR; Chernow B; Zaloga G; Labow J; Quirk R; Hedges SM
    Neuropsychopharmacology; 1988 May; 1(2):163-8. PubMed ID: 3251497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide.
    Sands CD; Jung KM; Jones DW; Kim HJ
    Clin Pharm; 1992 Feb; 11(2):168-73. PubMed ID: 1551298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation and treatment of autonomic circulatory failure.
    Wieling W; van Lieshout JJ
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):537-43. PubMed ID: 8400465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction to phenylpropalamine/chlorpheniramine/belladonna compound in a women with unrecognised autonomic dysfunction.
    Pentel P; Mikell F
    Lancet; 1982 Jul; 2(8292):274. PubMed ID: 6124702
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of phenylpropanolamine on ambulatory blood pressure.
    Goodman RP; Wright JT; Barlascini CO; McKenney JM; Lambert CM
    Clin Pharmacol Ther; 1986 Aug; 40(2):144-7. PubMed ID: 3731678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular studies of phenylpropanolamine.
    Vick J; Weiss L; Ellis S
    Arch Int Pharmacodyn Ther; 1994; 327(1):13-24. PubMed ID: 7944824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
    Segev G; Westropp JL; Kulik C; Lavy E
    Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic cardiac autonomic neuropathy].
    Ostermann G; Ricard Y; Varoquier C; Marchal E; Colmard P; Leutenegger M
    Journ Annu Diabetol Hotel Dieu; 1984; ():253-67. PubMed ID: 6399534
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
    Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
    JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional evaluation of autonomic neuropathies].
    Ferrer MT; Navarro X; Kennedy WR
    Med Clin (Barc); 1991 Mar; 96(8):303-8. PubMed ID: 2041404
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
    Dowse R; Scherzinger SS; Kanfer I
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.